Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cellular Decision On The Computer
http://www.medicalnewstoday.com/articles/115064.php
Scientists of the Division of Theoretical Bioinformatics at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg have simulated on the computer how cells decide whether or not to migrate.
Mitochondrial Cholesterol Makes Response To Chemotherapy Difficult In Hepatic Cancer
http://www.medicalnewstoday.com/articles/115063.php
Cancer is a disease characterized by important metabolic alterations. Not only do these adaptative changes give higher proliferative capacity to cancer cells, but they also contribute to higher resistance to chemotherapeutic agents.
Link Discovered Between DNA Palindromes And Disease
http://www.medicalnewstoday.com/articles/115030.php
<b>Study results could provide clue to origin of genome instability leading to cancers</b>In the past 10 years, researchers in genome stability have observed that many kinds of cancers are associated with areas where human chromosomes break.
Four New Research Grants Awarded To Help Fight 'Taboo' Disease, Prostate Cancer, UK
http://www.medicalnewstoday.com/articles/114998.php
The Prostate Cancer Charity is supporting four new research projects across the UK.The projects, totaling over £500,000, aim to increase scientific understanding of prostate cancer and benefit current and future generations of men affected by the disease and their partners and families.
Researchers Hone Technique To KO Pediatric Brain Tumors - Slow Release Is Key
http://www.medicalnewstoday.com/articles/114959.php
An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Ted Kennedy is suffering from.
Eight-Year Melanoma Remission Is Among Early Cancer Treatment Results
http://www.medicalnewstoday.com/articles/114938.php
A newly available treatment already has benefited several individuals with aggressive malignancies. Offered through NeoPlas Innovation, this regimen has arrested or eradicated tumors in more than 80% of initial patients.
Device Can Read Genetic Signature Of Circulating Tumour Cells To Guide Therapy
http://www.medicalnewstoday.com/articles/114915.php
A microchip-based device that detects and analyses tumour cells in the bloodstream proved effective in determining the genetic signature of lung tumours, allowing identification of patients appropriate for targeted treatment in a pilot study in patients with non-small-cell lung cancer (NSCLC).
Brain Cancer Study: Magnitude Of Post-Vaccine Immune Response Linked To Clinical Outcomes
http://www.medicalnewstoday.com/articles/114548.php
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal<i>Cancer Research.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
FDA Accepts Genta's NDA Amendment As Complete Response For Genasense(R) Treatment Of Chronic Lymphocytic Leukemia
http://www.medicalnewstoday.com/articles/114939.php
Genta Incorporated (OTC Bulletin Board: GNTA) announced that the Food and Drug Administration (FDA) has accepted the Company's amendment to its New Drug Application (NDA) for Genasense(R) (oblimersen sodium) Injection as a "complete response".
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Four New Research Grants Awarded To Help Fight 'Taboo' Disease, Prostate Cancer, UK
http://www.medicalnewstoday.com/articles/114998.php
The Prostate Cancer Charity is supporting four new research projects across the UK.The projects, totaling over £500,000, aim to increase scientific understanding of prostate cancer and benefit current and future generations of men affected by the disease and their partners and families.
Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
http://www.medicalnewstoday.com/articles/114956.php
Amgen (NASDAQ: AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer.
Bone Drug Reduces Fractures In Men Having Hormone Therapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/114954.php
Drugmaker Amgen Inc announced yesterday, Monday, that a large trial of its bone drug denosumab increased bone density and cut fractures in men with non-metastatic prostate cancer who were having hormone blocking therapy.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment